Agios Pharmaceuticals AGIO
NASDAQ AGIO
$32.82 +1.06 (+3.34%)
At close: Nov 11, 2026 · 4:00 PM EST

Agios Pharmaceuticals (AGIO) Return on Capital Employed [ROCE] (2013 - 2026)

Updated

Agios Pharmaceuticals' Return on Capital Employed [ROCE] came in at -42.64% for Q2 2026, down 10.66 percentage points from -31.98% a year earlier and down 2.42 percentage points from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends

For FY2025, Agios Pharmaceuticals' Return on Capital Employed [ROCE] was -33.77%, up 1.15 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +9.44 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -34.93% in FY2024 (+3.46 pp), -38.38% in FY2023 (-7.88 pp), -30.50% in FY2022 (+4.36 pp) and -34.86% in FY2021 (+8.35 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q2 2024.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for four consecutive quarters, with an average year-over-year change of +3.44 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2025 (a gain of 22.11 percentage points), and the weakest in Q2 2024 (a drop of 18.86 percentage points).
  • Business Quant data shows AGIO's Return on Capital Employed [ROCE] at -40.22% (Q1 2026), -37.49% (Q4 2025) and -35.13% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Agios Pharmaceuticals 1.90 Bn -940.41 Mn 52.86 Mn -41.57%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -41.57%
Jun 30, 2026 -42.64%
Mar 31, 2026 -40.22%
Dec 31, 2025 -37.49%
Sep 30, 2025 -35.13%
Jun 30, 2025 -31.98%
Mar 31, 2025 -28.28%
Dec 31, 2024 -25.86%
Sep 30, 2024 -34.99%
Jun 30, 2024 -54.10%
Mar 31, 2024 -46.68%
Dec 31, 2023 -43.29%
Sep 30, 2023 -38.91%
Jun 30, 2023 -35.23%
Mar 31, 2023 -32.92%
Dec 31, 2022 -33.92%
Sep 30, 2022 -33.94%
Jun 30, 2022 -31.69%
Mar 31, 2022 -28.96%
Dec 31, 2021 -26.47%
API Access

Agios Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AGIO&period=max&api_key=YOUR_API_KEY